The company has conditionally raised £3m with the explicit intention of accelerating growth across all markets, but particularly the US in which it will launch a potentially disruptive business model – its High Usage Program (HUP) whereby customers are able to use a hemodynamic monitor on a high-usage basis for an up-front fee. With evidence that a focused approach to sales in the US has already generated improved results as illustrated by the +37% US growth in 1H FY 2017, LiDCO i
07 Dec 2016
£3m placing to fund US expansion
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
£3m placing to fund US expansion
- Published:
07 Dec 2016 -
Author:
Mark Brewer -
Pages:
20
The company has conditionally raised £3m with the explicit intention of accelerating growth across all markets, but particularly the US in which it will launch a potentially disruptive business model – its High Usage Program (HUP) whereby customers are able to use a hemodynamic monitor on a high-usage basis for an up-front fee. With evidence that a focused approach to sales in the US has already generated improved results as illustrated by the +37% US growth in 1H FY 2017, LiDCO i